Prices are updated after-hours

skin

Clinuvel Pharmaceuticals Ltd

CLVLF | $8.9 53.4% 2K

(0.0% 1d) (0.0% 1m) (-33.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (150.0% volume)
Earnings Calendar:
Market Cap: $ 446,132,703
http://www.clinuvel.com
Sec Filling | Patents | n/a employees

(AU) Clinuvel Pharmaceuticals Ltd. is a global biopharmaceutical company. It engages in the the development of SCENESSE, its proprietary photoprotective drug. It also offers drugs for the treatment of various skin disorders. The company was founded by Robert Thomas Dorr on December 14, 1999 and is headquartered in Melbourne, Australia.

skin treatment

add to watch list Paper trade email alert is off

Kose Corporation/ADR

KOSCF | $49.395 0.28% 50

n/a

(0.0% 1d) (-3.9% 1m) (-58.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-51.92% volume)
Earnings Calendar:
Market Cap: $ 2,992,968,563
http://www.kose.co.jp
Sec Filling | Patents | n/a employees

(JP) KOSÉ Corp. manufactures and distributes cosmetic products. It operates through the following business segments: Cosmetics, Cosmetaries, and Others. The Cosmetics segment includes the production and sales of cosmetics, such as make-up and perfume. The Cosmetaries segment involves in the production and sale of other skin care products, such as soap, lotion, toner, and facial cleanser, as well as hair care products, like shampoo, conditioner, and rinse. The Other segment consists of activities, such as amenities management and real estate leasing. The company was founded by Kozaburo Kobayashi on March 2, 1946 and is headquartered in Tokyo, Japan.

skin

add to watch list Paper trade email alert is off

Biofrontera AG

BFFTF | $1.08 0% 400

n/a

(0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (185.71% volume)
Earnings Calendar:
Market Cap: $ 68,911,623
http://biofrontera.com
Sec Filling | Patents | n/a employees

(DE) Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

msa treatment skin

add to watch list Paper trade email alert is off

COLOPLAST A/S

CLPBF | $124.23 -17.82% 20

Health Technology

(0.0% 1d) (-8.6% 1m) (-13.6% 1y) (0.0% 2d) (0.0% 3d) (-3.8% 7d) (900.0% volume)
Earnings Calendar:
Market Cap: $ 26,113,146,000
http://www.coloplast.com
Sec Filling | Patents | n/a employees

(DK) Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

skin

add to watch list Paper trade email alert is off

LVMH MOET HENNESSY LOUIS VUITTON

LVMHF | $843.8822 3.7% 1.1K

Consumer Non-Durables

(0.0% 1d) (-4.5% 1m) (-14.5% 1y) (0.0% 2d) (0.0% 3d) (-0.7% 7d) (40.25% volume)
Earnings Calendar:
Market Cap: $ 423,123,176,430
http://www.lvmh.com
Sec Filling | Patents | n/a employees

(FR) LVMH Moët Hennessy Louis Vuitton SE engages in the manufacture of luxury goods. It operates through the following business segments: Wines & Spirits, Fashion & Leather Goods, Perfumes & Cosmetics, Watches & Jewelry, Selective Retailing, and Other Activities & Eliminations. The Wines & Spirits segment produces and sells high quality champagne wines and sparkling wines. It also distributes vodka and white liquor. The Fashion & Leather Goods segment engages in the manufacture of luggage items, bags, accessories, shoes and clothes. The Perfumes & Cosmetics segment engages in the production and distribution of make-up, perfume and skin care products. The Watches & Jewelry segment manufactures luxury watches and accessories form men and women. It specializes in the field of chronographs and ultimate precision. The Selective Retailing segment is organized to promote an environment that is appropriate to the image and status of the luxury brands. It engages in the sale of luxury products to international travelers and on board cruise ships. This segment also manages beauty stores that combine direct access and customer assistance to customers. The Other Activities & Eliminations segment includes media division. It publishes newspapers and magazines, manages business and financial websites and holds radio stations. This segment also engages in the real estate industry and builds luxury yachts. The company was founded on January 1, 1987 and is headquartered in Paris, France.

brands skin women fashion

add to watch list Paper trade email alert is off

Croda International Plc/ADR

COIHF | $61.01 43.36% 430

Process Industries

(0.0% 1d) (-1.0% 1m) (-29.9% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-52.43% volume)
Earnings Calendar:
Market Cap: $ 8,519,158,316
http://croda.com
Sec Filling | Patents | n/a employees

(GB) Croda International Plc engages in the manufacture and sale of specialty chemicals. It operates through the following business segments: Personal Care, Life Sciences, Performance Technologies, and Industrial Chemicals. The Personal Care segment offers a range of speciality sustainable skin care, hair care, and solar protection ingredients. The Life Sciences segment includes crop care and healthcare speciality ingredients. The Performance Technologies segment supports the circular economy and durable material design, enabling the growth of clean energy, and helping to further reduce negative environmental impact. The Industrial Chemicals segment focuses on its biosurfactant plant at Atlas Point in North America. The company was founded by George Crowe and Dawe on May 25, 1925 and is headquartered in Goole, the United Kingdom.

education skin energy solar

add to watch list Paper trade email alert is off

FALCONSTOR SOFTWARE INC

FALC | $2.13 -46.95% 500

Information

(0.0% 1d) (12.1% 1m) (97.2% 1y) (0.0% 2d) (0.0% 3d) (18.3% 7d) (-82.38% volume)
Earnings Calendar:
Market Cap: $ 15,196,494
https://falconstor.com/
Sec Filling | Patents | 45 employees

(US) FalconStor is a data management software company based in Austin, Texas. FalconStor was co-founded in 2000 in New York by Computer Associates veterans ReiJane Huai and Wayne Lam. In 2007 the company started a joint-venture with the Chinese Academy of Sciences for the Blue Whale file system. The joint venture was named Tianjin Zhongke Blue Whale Information Technologies Company, located in Tianjin, China.[citation needed] FalconStor was listed at #5 in the Forbes 2008 list of 25 fastest growing technology companies. In August 2009, FalconStor, in a joint-venture with Nexsan to create the co-branded DeDupe SG. In 2011 CRN added FalconStor to their List of 25 “Need to Know: Storage Vendors”.

brands skin information technology computational

add to watch list Paper trade email alert is off

Fresh Tracks Therapeutics Inc

FRTX 4 | $0.91 4.39% 17K

Manufacturing

(0.0% 1d) (4.6% 1m) (39.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-7.27% volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 5,435,708
https://brickellbio.com
Sec Filling | Patents | 13 employees

(US) Brickell Biotech, Inc. is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated prescription therapeutics for debilitating skin diseases with a focus on its lead asset sofpironium bromide for the treatment of hyperhidrosis. Brickell's executive management team and board of directors bring extensive experience in product development and global commercialization, having served in leadership roles at large global pharmaceutical companies and biotechs that have developed and/or launched successful products, including several that were first-in-class and/or achieved iconic status, such as Cialis®, Taltz®, Gemzar®, Prozac®, Cymbalta® and Juvederm®. Brickell's strategy is to leverage this experience to in-license, acquire, develop and commercialize innovative and differentiated pharmaceutical products that Brickell believes can be successful in the marketplace and transform lives by solving currently unmet patient needs.

treatment skin

add to watch list Paper trade email alert is off

Beauty Health Company (The) - Class A

SKIN | $3.23 -1.22% -1.24% 1.2M

Professional, Scientific, and T...

(0.0% 1d) (-20.4% 1m) (-74.0% 1y) (0.0% 2d) (0.0% 3d) (-1.2% 7d) (-13.31% volume)
Earnings Calendar: 2024-03-12
Market Cap: $ 398,773,613
https://www.beautyhealth.com/
Sec Filling | Patents | n/a employees

BeautyHealth is a category-creating beauty health company focused on bringing innovative products to market. Its flagship brand, HydraFacial, is a non-invasive and approachable beauty health platform and ecosystem with a powerful community of estheticians, consumers and partners, bridging medical and consumer retail to democratize and personalize skin care solutions for the masses. Leading the charge in beauty health as a category-creator, HydraFacial uses a unique delivery system to cleanse, extract, and hydrate with their patented hydradermabrasion technology and super serums that are made with nourishing ingredients, providing an immediate outcome and creating an instantly gratifying glow in just three steps and 30 minutes. HydraFacial® and Perk™ products are available in over 87 countries with over 16,000 delivery systems globally and millions of treatments performed each year.

brands msa skin treatment 3d

add to watch list Paper trade email alert is off

REPLICEL LIFE SCIENCES INC.

REPCF | $0.0428 414.71% 550

Non-Energy Minerals

(0.0% 1d) (0.0% 1m) (-54.2% 1y) (0.0% 2d) (4.9% 3d) (0.0% 7d) (-94.49% volume)
Earnings Calendar:
Market Cap: $ 2,782,067
http://www.replicel.com
Sec Filling | Patents | n/a employees

(CA) RepliCel Life Sciences, Inc. operates as a regenerative medicine company. The company focuses on developing autologous cell therapies that address conditions linked to a deficit of healthy cells required for normal healing and function. Its products includes RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin, and pattern baldness. The company was founded on April 24, 1967 and is headquartered in Vancouver, Canada.

msa skin t-cell ceiling

add to watch list Paper trade email alert is off

Nexgel Inc

NXGL | $2.18 4.41% 1.4K

Manufacturing

(0.0% 1d) (-20.1% 1m) (41.6% 1y) (0.0% 2d) (0.0% 3d) (-3.1% 7d) (741.45% volume)
Earnings Calendar: 2023-03-27
Market Cap: $ 13,576,220
https://nexgel.com
Sec Filling | Patents | 8 employees

NEXGEL advanced hydrogel solutions is your skin friendly patch company! Its ultra-gentle, high-water content hydrogels are an excellent transdermal drug delivery system for a broad range of OTC and Cosmetic ingredients. Its hydrogels are gentler than most because NEXGEL doesn’t use chemical cross-linking agents or chemical adhesives to deliver its ingredients. Instead, NEXGEL uses a unique electron-beam cross linking process to create the bond. By using NEXGEL you can rest assured that you have one of the gentlest transdermal delivery systems on the market.

skin electronics

add to watch list Paper trade email alert is off

European Wax Center Inc - Class A

EWCZ | News | $11.77 1.29% 1.27% 300K

(0.0% 1d) (-8.2% 1m) (-40.0% 1y) (0.0% 2d) (0.0% 3d) (2.6% 7d) (Infinity% volume)
Earnings Calendar: 2022-08-04
Market Cap: $ 572,110,416
https://www.waxcenter.com
Sec Filling | Patents | 2021 employees

European Wax Center, Inc. is a leading personal care franchise brand founded in 2004. They offer expert wax services from certified Wax Specialists, ensuring that every guest who walks through the door leaves feeling confident—in European Wax Center and themselves. European Wax Center provides guests with a first class, professional waxing experience by the most highly trained estheticians in the industry, within the privacy of clean, individual waxing suites. They’re so certain everyone will love the European Wax Center experience, European Wax Center offers a free complimentary wax to each new guest. European Wax Center continues to revolutionize the waxing category with their innovative, signature Comfort Wax™. This proprietary blend is formulated with the highest quality ingredients to leave skin feeling smooth and make waxing an efficient and relatively painless experience. To help enhance and extend waxing services after leaving the center, European Wax Center offers a full collection of proprietary products in the skincare, body, and brow categories. European Wax Center is a leading wax specialty personal care brand in the United States, and its network now includes 808 centers nationwide.

brands skin

add to watch list Paper trade email alert is off

Journey Medical Corp

DERM | $3.59 1.41% 1.39% 75K

(0.0% 1d) (21.2% 1m) (118.5% 1y) (0.0% 2d) (0.0% 3d) (1.7% 7d) (-63.37% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 50,016,993
https://journeymedicalcorp.com
Sec Filling | Patents | 2021 employees

Journey is focused on identifying, acquiring and strategically commercializing innovative, differentiated dermatology products through its efficient sales and marketing model. The Journey team is comprised of industry experts with extensive experience commercializing some of the most successful prescription dermatology brands. Journey was formed in 2014 and is a subsidiary of Fortress Biotech, Inc. Journey’s core purpose is to positively impact people’s lives and well-being by providing effective solutions for treating skin conditions, healing wounds and supporting healthy skin.

brands skin

add to watch list Paper trade email alert is off

UNILEVER PLC

UNLYF | $47.6 1.3% 1.4K

Consumer Non-Durables

(0.0% 1d) (-6.4% 1m) (-11.2% 1y) (0.0% 2d) (0.0% 3d) (1.3% 7d) (420.0% volume)
Earnings Calendar:
Market Cap: $ 120,272,522,787
https://www.unilever.co.uk/
Sec Filling | Patents | n/a employees

(GB) Unilever Plc is a multinational consumer goods company that provides fast moving consumer goods. Its product categories include savoury, dressings and spread; ice cream and beverages; personal care, and home care. The company's brands include Axe & Lynx, Blue Band, Dove, Becel & Flora, Heartbrand ice creams, Hellmann's, Knorr, Lipton, Lux, Omo, Rexona and Sunsilk. It operates in three regions: Asia, Africa and Central and Eastern Europe, the Americas and Western Europe. The company's product areas are Personal Care, Foods, Refreshment and Home Care. Its Personal Care products include skin care and hair care products, deodorants and oral care products. The company Food products include soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads, and cooking products such as liquid margarines. Its Refreshment products include ice cream, tea-based beverages, weight-management products, and nutritionally enhanced staples sold in developing markets. The company Home Care products include laundry tablets, powders and liquids, soap bars and a range of cleaning products. Unilever was founded by Antonius Johannes Jurgens, Samuel van den Bergh and William Hulme Lever on January 1, 1930 and is headquartered in London, the United Kingdom.

brands urea skin liver

add to watch list Paper trade email alert is off

MoonLake Immunotherapeutics - Class A

MLTX | $43.24 5.41% 5.13% 580K

(0.0% 1d) (-20.7% 1m) (71.9% 1y) (0.0% 2d) (0.0% 3d) (-5.7% 7d) (-47.55% volume)
Earnings Calendar:
Market Cap: $ 2,718,699,304

Sec Filling | Patents | 20 employees

moonlake immunotherapeutics ag is a clinical-stage biopharmaceutical company leveraging revolutionary nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

add to watch list Paper trade email alert is off

Strata Skin Sciences, Inc.

SSKN | $0.554 4.53% 4.33% 7.5K

Health Technology

(0.0% 1d) (8.2% 1m) (-49.4% 1y) (0.0% 2d) (0.0% 3d) (1.9% 7d) (NaN% volume)
Earnings Calendar: 2024-03-27
Market Cap: $ 19,423,750
http://www.strataskinsciences.com
Sec Filling | Patents | 115 employees

(US) STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. It engages in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through the following segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. The Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. The company was founded by Dina Gutkowicz-Krusin in December 1989 and is headquartered in Horsham, PA.

skin security treatment

add to watch list Paper trade email alert is off

BANCO BILBAO VIZCAYA ARGENTARIA, S.A.

BBVXF | $10.8 -0.74% 310

Finance

(0.0% 1d) (-5.7% 1m) (43.4% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-72.13% volume)
Earnings Calendar:
Market Cap: $ 63,983,826,569
http://bbvauk.com
Sec Filling | Patents | n/a employees

(ES) Banco Bilbao Vizcaya Argentaria SA engages in the traditional banking businesses of retail banking, asset management, private banking, and wholesale banking. It operates through the following segments: Spain, the United States, Mexico, Turkey, South America, and Rest of Eurasia. The Spain segment includes mainly the banking and insurance business that the group carries out in Spain. The United States segment consists of the financial business activity of BBVA USA in the country and the activity of the branch of BBVA SA in New York. The Mexico segment refers to banking and insurance businesses in this country as well as the activity of its branch in Houston. The Turkey segment reports the activity of Garanti BBVA group that is mainly carried out in this country and, to a lesser extent, in Romania and the Netherlands. The South America segment comprises of operations in n Argentina, Colombia, Peru, Uruguay, and Venezuela. The Rest of Eurasia segment includes the banking business activity carried out by the group in Europe and Asia, excluding Spain. The company was founded on June 1, 1988 and is headquartered in Madrid, Spain.

skin

add to watch list Paper trade email alert is off

Dermata Therapeutics Inc

DRMA | $0.342 -2.68% -2.75% 19K

(0.0% 1d) (-15.7% 1m) (-82.8% 1y) (0.0% 2d) (0.0% 3d) (9.4% 7d) (32.45% volume)
Earnings Calendar: 2024-02-20
Market Cap: $ 2,278,007
https://www.dermatarx.com
Sec Filling | Patents | 2021 employees

Dermata is a clinical-stage biotechnology company focused on making major advancements in the treatment of medical and aesthetic skin diseases and conditions. Dermata has a team of experienced individuals who are currently focused on progressing two programs for the treatment of acne, psoriasis, rosacea and aesthetic indications.

treatment skin

add to watch list Paper trade email alert is off

INMODE LTD.

INMD | $17.375 1.37% 1.35% 920K

Health Technology

(0.0% 1d) (-16.2% 1m) (-54.6% 1y) (0.0% 2d) (0.0% 3d) (-1.8% 7d) (-36.91% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 1,459,195,277
http://www.inmodemd.com
Sec Filling | Patents | 251 employees

InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.

skin israel aesthetic treatment

add to watch list Paper trade email alert is off

PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT 4 | $0.1948 -15.0% 63K

Manufacturing

(0.0% 1d) (-5.0% 1m) (37.7% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-68.09% volume)
Earnings Calendar:
Market Cap: $ 81,718,039
http://www.provectusbio.com/
Sec Filling | Patents | 2 employees

(US) provectus biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer. provectus’ investigational oncology drug, pv-10, is an ablative immunotherapy under investigation in solid tumor cancers.

add to watch list Paper trade email alert is off